Skip to main content
Premium Trial:

Request an Annual Quote

EMBL, Belgium s SARS Center Create Research Partnership

NEW YORK, June 19 - The European Molecular Biology Laboratory and the Belgium-based Sars International Center will collaborate on certain scientific research, including genomic, molecular, and cellular research.

 

A "major goal" of the agreement, called the Partnership in Marine Molecular Biology, is to "facilitate scientific exchange and collaborations." The groups will organize joint scientific meetings "to exchange information on current projects, stimulate in a bottom-up manner future collaborations and personnel exchange between the two institutions and others, and thus assemble a scientific community of critical mass interested in marine molecular biology," according to the partners. The institutes will also support joint funding applications.

The institutes will also provide access to each other's facilities, databases, and instrumentation for visiting scientists. These include the marine biology infrastructures in Bergen, Norway, where the Sars center has its headquarters, and the EMBL's facilities for genomics, proteomics, functional genomic, and advanced light microscopy facilities in Heidelberg, Germany.


The Sars Center will establish an International PhD Program in marine molecular biology. Students will receive research training at the Sars Center, while the University of Bergen, the EMBL, and "other international institutes" will plan the program's theoretical and practical course work.

An agreement for joint PhD degrees from the University of Bergen and EMBL is "currently being negotiated" and will join the partnerships that EMBL has with universities throughout its member states.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.